Delivery Order SPE2DB24D9144-SPE2DB24FCMJR

Award Date 8/12/24
Potential Completion Date 9/3/24
Potential Value $30K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $13,900.02 firm fixed-price delivery order is for the supply of Entyvio 300 mg vials, a biologic medication. The award is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. This single-award IDC allows the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $55,600.08 firm fixed-price delivery order is for the provision of Entyvio 300 mg vials, a specialized pharmaceutical product. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to issue delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $9,889.86 firm fixed-price delivery order is for the supply of Entyvio 300 mg vials, a specialized pharmaceutical product. The contract is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. This IDC enables the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $39,429.44 firm fixed-price delivery order is for the supply of Entyvio 300 mg vials, a specialized pharmaceutical product. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue delivery orders for...
This federal contract award was issued by the Defense Logistics Agency (DLA), a defense agency, to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $59,144.16 firm fixed-price delivery order is for the supply of Entyvio 300 mg vials to support the recurring medical supply needs of military health facilities. The contract is part of a larger indefinite delivery contract (IDC) valued up to $499,999,999 that DMS...
This federal contract award, valued at $94,515.80, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order for the provision of Entyvio 300 mg vials, a specialized pharmaceutical product. DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $14,210.73 firm fixed-price delivery order is for the supply of Entyvio 300 mg vials to fulfill recurring medical supply needs of military health facilities worldwide. DMS Pharmaceutical Group holds a $499,999,999 indefinite delivery contract (IDC) with DLA under the SPE2DB program, which allows...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $73,930.20 firm fixed-price delivery order is for the supply of Entyvio 300 mg vials, a biologic medication. The contract has no set-aside designation and is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. This...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at up to $98,573.60, is for the delivery of Entyvio 300 mg vials, a specialized biologic medication used to treat certain gastrointestinal conditions. The contract is a firm fixed-price delivery order with no set-aside designation, leveraging DMS Pharmaceutical Group's status as a woman-owned small business...
This federal contract award, valued at $9,473.84, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order for the supply of Entyvio 300 mg vials, a biologic medication used to treat certain gastrointestinal disorders. The award is part of a larger indefinite delivery contract (IDC) held by DMS Pharmaceutical Group Inc. with the DLA...
  • SPE2DB24D9144
    Indefinite Delivery Contract
  • SPE2DB24D9144-SPE2DB24FCMJR
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The award, valued at $29,572.08, is a firm fixed-price delivery order for the supply of Entyvio 300 mg vials.

The contract is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. This single-award IDC allows the DLA to issue delivery orders for a comprehensive range of pharmaceutical items to fulfill the recurring medical supply needs of military health facilities worldwide. Through this vehicle, DMS Pharmaceutical Group provides both routine and specialized medications to support the diverse medical requirements of the Department of Defense (DoD) healthcare system.

The contract does not have a set-aside designation, as DMS Pharmaceutical Group's status as a woman-owned small business allows the company to secure direct awards for pharmaceutical Prime Vendor programs supporting military medical facilities globally.

Generated 11/11/24, 9:18 AM